Submit Deal

SARSIA

Summary

Sarsia is the largest early-phase venture capital firm investing in life-science companies.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 84 M

Avg. Deal Size£ 42 M

Market Context

Senior Management

Sort

calluna pharma

HQ - Norway

Biotechnology

23 Jan 2024

Investment Date

£ 64 M

Deal Value

heimdall power

HQ - Norway

Renewable Energy Equipment

16 Jul 2024

Investment Date

£ 19 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy